14/05/2026
Polycystic O***y Syndrome (PCOS)âāĻāϰ āύāĻžāĻŽ āĻĒāϰāĻŋāĻŦāϰā§āϤāύā§āϰ āĻĒā§āϰāϏā§āϤāĻžāĻŦ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āĻāύā§āϤāϰā§āĻāĻžāϤāĻŋāĻ āĻŽā§āĻĄāĻŋāĻā§āϞ āĻāĻŽāĻŋāĻāύāĻŋāĻāĻŋāϤ⧠āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻāϞā§āĻāύāĻžāϰ āĻŦāĻŋāώ⧠āĻšā§ā§ āĻāĻ ā§āĻā§āĨ¤ International evidence-based consensus process āĻāĻŦāĻ The LancetâāĻ āĻĒā§āϰāĻāĻžāĻļāĻŋāϤ āϏāĻžāĻŽā§āĻĒā§āϰāϤāĻŋāĻ āĻŦā§āĻā§āĻāĻžāύāĻŋāĻ āĻāϞā§āĻāύāĻžā§ PCOSâāĻāϰ āĻāύā§āϝ āύāϤā§āύ āύāĻžāĻŽ āĻšāĻŋāϏā§āĻŦā§ āĻĒā§āϰāϏā§āϤāĻžāĻŦ āĻāϰāĻž āĻšā§ā§āĻā§:
Polyendocrine Metabolic Ovarian Syndrome (PMOS)
āĻāĻ āϰāĻŋāύā§āĻŽāĻŋāĻ āĻāύāĻŋāĻļāĻŋāϝāĻŧā§āĻāĻŋāĻā§āϰ āĻŽā§āϞ āĻāĻĻā§āĻĻā§āĻļā§āϝ āĻšāϞ⧠āĻāύā§āĻĄāĻŋāĻļāύāĻāĻŋāϰ āĻĒā§āϰāĻā§āϤ āĻĒā§āϝāĻžāĻĨā§āĻĢāĻŋāĻāĻŋāĻāϞāĻāĻŋ āĻāĻŦāĻ āĻā§āϞāĻŋāύāĻŋāĻā§āϝāĻžāϞ āĻĒā§āϰā§āĻā§āύā§āĻā§āĻļāύāĻā§ āĻāϰāĻ āϝāĻĨāĻžāϝāĻĨāĻāĻžāĻŦā§ āĻāĻĒāϏā§āĻĨāĻžāĻĒāύ āĻāϰāĻžāĨ¤ āύāϤā§āύ āĻāĻžāĻāĻĄāϞāĻžāĻāύ āϧāĻžāĻĒā§ āϧāĻžāĻĒ⧠⧍ā§Ļā§¨ā§Ž āϏāĻžāϞā§āϰ āĻŽāϧā§āϝ⧠āĻāĻŽāĻĒā§āϞāĻŋāĻŽā§āύā§āĻ āĻšāĻā§āĻžāϰ āĻĒāϰāĻŋāĻāϞā§āĻĒāύāĻž āϰā§ā§āĻā§āĨ¤
āĻĻā§āϰā§āĻāĻĻāĻŋāύ āϧāϰā§āĻ âPCOSâ āύāĻžāĻŽāĻāĻŋ āύāĻŋā§ā§ āĻā§āϞāĻŋāύāĻŋāĻļāĻŋāϝāĻŧāĻžāύ āĻ āĻāĻŦā§āώāĻāĻĻā§āϰ āĻŽāϧā§āϝ⧠āĻāϞā§āĻāύāĻž āĻāĻŋāϞāĨ¤ āĻāĻžāϰāĻŖ, âPolycysticâ āĻļāĻŦā§āĻĻāĻāĻŋ āĻ
āύā§āĻ āĻā§āώā§āϤā§āϰā§āĻ āĻŦāĻŋāĻā§āϰāĻžāύā§āϤāĻŋāĻāϰāĨ¤ āĻāĻŦā§āώāĻŖāĻžā§ āĻĻā§āĻāĻž āϝāĻžā§, āĻāϞā§āϞā§āĻāϝā§āĻā§āϝ āϏāĻāĻā§āϝāĻ āĻĒā§āĻļā§āύā§āĻā§āϰ ovariesâāĻ classic cystic appearance āύāĻžāĻ āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻāĻāĻžā§āĻž āύāĻžāĻŽāĻāĻŋ conditionâāĻāĻŋāϰ reproductive aspectâāĻā§ āĻŦā§āĻļāĻŋ āĻā§āϰā§āϤā§āĻŦ āĻĻāĻŋāϞā§āĻ āĻāϰ metabolic, endocrine, inflammatory āĻāĻŦāĻ psychological impactâāĻā§āϞ⧠āĻ
āύā§āĻāĻžāĻāĻļā§ āĻā§āĻžāϞ⧠āĻĨā§āĻā§ āϝāĻžā§āĨ¤
āĻŦāϰā§āϤāĻŽāĻžāύ evidence āĻ
āύā§āϝāĻžā§ā§ PCOS/PMOS āĻļā§āϧā§āĻŽāĻžāϤā§āϰ āĻāĻāĻāĻŋ ovarian disorder āύā§; āĻŦāϰāĻ āĻāĻāĻŋ āĻāĻāĻāĻŋ multisystem endocrine-metabolic condition, āϝāĻž insulin resistance, obesity, dyslipidemia, type 2 diabetes, cardiovascular risk āĻāĻŦāĻ mental health disturbancesâāĻāϰ āϏāĻžāĻĨā§ āĻāύāĻŋāώā§āĻ āĻāĻžāĻŦā§ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤāĨ¤
āύāϤā§āύ terminology āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻĢāϞ⧠āϝā§āϏāĻŦ āĻā§āώā§āϤā§āϰ⧠āĻāϤāĻŋāĻŦāĻžāĻāĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāϏāϤ⧠āĻĒāĻžāϰā§:
â Earlier and more comprehensive diagnosis
â Insulin resistance āĻ metabolic dysfunctionâāĻāϰ better recognition
â FertilityâāĻāϰ āĻŦāĻžāĻāϰā§āĻ systemic symptomsâāĻāϰ clinical āĻā§āϰā§āϤā§āĻŦ āĻŦā§āĻĻā§āϧāĻŋ
â Multidisciplinary treatment approachâāĻāϰ āĻāύā§āύā§āύ
â Research funding āĻ public awareness āĻŦā§āĻĻā§āϧāĻŋ
â Long-term complications preventionâāĻ stronger focus
āϤāĻŦā§ terminology āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻšāϞā§āĻ āĻāĻŋāĻā§ core management principles āĻ
āĻĒāϰāĻŋāĻŦāϰā§āϤāĻŋāϤ āĻĨāĻžāĻāĻŦā§:
âĸ Medical Nutrition Therapy āĻāĻāύāĻ managementâāĻāϰ cornerstone
âĸ Lifestyle modification remains essential
âĸ Individualized patient-centered care āĻ
āϤā§āϝāύā§āϤ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ
âĸ Sustainable dietary and behavioral interventionâāĻāϰ āĻā§āĻŽāĻŋāĻāĻž āĻ
āĻĒāϰāĻŋāĻšāĻžāϰā§āϝ
āĻāĻāĻāύ Dietician āĻšāĻŋāϏā§āĻŦā§ āĻāĻŽāĻŋ āĻŦāĻŋāĻļā§āĻŦāĻžāϏ āĻāϰāĻŋ, āĻāĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ womenâs metabolic and reproductive healthâāĻā§ āĻāϰāĻ holistic, evidence-based āĻāĻŦāĻ patient-centered perspectiveâāĻ āĻĻā§āĻāĻžāϰ āϏā§āϝā§āĻ āϤā§āϰāĻŋ āĻāϰāĻŦā§āĨ¤ āĻāĻāĻŋ āĻļā§āϧ⧠āĻāĻāĻāĻŋ āύāĻžāĻŽ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āύā§; āĻŦāϰāĻ conditionâāĻāĻŋāϰ scientific understanding āĻāĻŦāĻ clinical approachâāĻāϰ āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ evolutionāĨ¤